The Cancer Letter

Inside information on cancer research and drug development

Drugs & Targets

Shasqi, Johnson & Johnson expand existing research collaboration

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Shasqi, Inc. and Johnson & Johnson Enterprise Innovation Inc. have expanded their ongoing research collaboration.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

In Brief

Victor Ambros and Gary Ruvkun share 2024 Nobel Prize in Physiology or Medicine

Victor AmbrosPhoto credit: Niklas Elmehed © Nobel Prize OutreachGary RuvkunPhoto credit: Niklas Elmehed © Nobel Prize OutreachVictor Ambros and Gary Ruvkun were jointly awarded the 2024 Nobel Prize in Physiology or Medicine from the Nobel Assembly at the Karolinska Institutet. The two scientists are being honored for their discovery of microRNA and its role in post-transcriptional gene regulation.
In Brief

Moungi G. Bawendi, Louis E. Brus, Alexei I. Ekimov awarded 2023 Nobel Prize in Chemistry for quantum dots

Moungi Bawendi (left), Louis Brus (center) and Alexei Ekimov (right)Photo credit: Niklas Elmehed © Nobel Prize OutreachMoungi G. Bawendi, Louis E. Brus, and Alexei I. Ekimov were jointly awarded the 2023 Nobel Prize in Chemistry for their discovery and development of quantum dots—nanoparticles so tiny that their size determines their properties. These smallest components of nanotechnology now spread their light from televisions and LED lamps, and can also guide surgeons when they remove tumor tissue, among many other applications.
Table of Contents

Login

Site license subscribers:
Log in with your IP | Register a sponsored account